The landscape of dementia analysis has advanced drastically with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology many years ahead of indications arise. Although these technological advancements stand for outstanding progress in knowledge neurodegenera